The current valuation score of Aclarion Inc is 8.44, ranking 134 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.54, which is -99.72% below the recent high of -0.00 and -214.39% above the recent low of -1.70.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.